IL193400A0 - Polymorphs of eszopiclone malate - Google Patents

Polymorphs of eszopiclone malate

Info

Publication number
IL193400A0
IL193400A0 IL193400A IL19340008A IL193400A0 IL 193400 A0 IL193400 A0 IL 193400A0 IL 193400 A IL193400 A IL 193400A IL 19340008 A IL19340008 A IL 19340008A IL 193400 A0 IL193400 A0 IL 193400A0
Authority
IL
Israel
Prior art keywords
polymorphs
eszopiclone malate
eszopiclone
malate
Prior art date
Application number
IL193400A
Original Assignee
Teva Pharma
Wizel Shlomit
Lieberman Anita
Mendelovici Marioara
Koltai Tamas
Mainfeld Alex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Wizel Shlomit, Lieberman Anita, Mendelovici Marioara, Koltai Tamas, Mainfeld Alex filed Critical Teva Pharma
Publication of IL193400A0 publication Critical patent/IL193400A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
IL193400A 2006-03-23 2008-08-12 Polymorphs of eszopiclone malate IL193400A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78595906P 2006-03-23 2006-03-23
US88886607P 2007-02-08 2007-02-08
PCT/US2007/064825 WO2007109799A2 (en) 2006-03-23 2007-03-23 Polymorphs of eszopiclone malate

Publications (1)

Publication Number Publication Date
IL193400A0 true IL193400A0 (en) 2009-08-03

Family

ID=38523334

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193400A IL193400A0 (en) 2006-03-23 2008-08-12 Polymorphs of eszopiclone malate

Country Status (3)

Country Link
US (2) US20080027223A1 (en)
IL (1) IL193400A0 (en)
WO (1) WO2007109799A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020403A1 (en) 2007-08-02 2009-02-04 Esteve Quimica, S.A. Process for the resolution of zopiclone and intermediate compounds
US8198278B2 (en) * 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8212036B2 (en) 2007-12-19 2012-07-03 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8269005B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
US8198277B2 (en) * 2007-12-19 2012-06-12 Sunovion Pharmaceuticals Inc. L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
CA2747008C (en) * 2007-12-19 2017-12-12 Richard Hsia Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
US8268832B2 (en) * 2007-12-19 2012-09-18 Sunovion Pharmaceuticals Inc. Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
SG173014A1 (en) 2009-01-16 2011-08-29 Exelixis Inc Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
US20110009416A1 (en) * 2009-07-07 2011-01-13 Sepracor Inc. PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
KR102495018B1 (en) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04285A (en) * 1972-01-07 1979-12-31 Rhone Poulenc Sa New derivatives of pyrrolo (3,4-b) pyrazine and their preparation.
FR2671800B1 (en) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US6339086B1 (en) * 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
ES2203319B1 (en) * 2002-04-03 2005-03-01 Universidad De Oviedo NEW OPTICALLY ACTIVE CARBONATES AS INTERMEDIATES IN THE SYNTHESIS OF (+) - ZOPICLONA.
US7476737B2 (en) * 2005-09-05 2009-01-13 Dr. Reddy's Laboratories Limited Eszopiclone process
US20070203145A1 (en) * 2006-02-03 2007-08-30 Jie Zhu Zopiclone resolution
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone

Also Published As

Publication number Publication date
US20090076272A1 (en) 2009-03-19
WO2007109799A3 (en) 2008-04-24
US20080027223A1 (en) 2008-01-31
WO2007109799A2 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
HK1245264A1 (en) Polymorphs
IL193400A0 (en) Polymorphs of eszopiclone malate
IL195158A0 (en) Novel heterocyclic compounds
HK1132268A1 (en) Novel anxiolytic compounds
IL197956A0 (en) Polymorphs of nicotinic intermediates
GB0712783D0 (en) Preparation of oxycodone
EP2212305A4 (en) Beta-lactone compounds
EP1981596A4 (en) Novel compounds
GB0701145D0 (en) Freedom shower
EP2057144A4 (en) Novel polymorphs of rimonabant
GB0618703D0 (en) Synthesis of leikotriene compounds
IL186301A0 (en) Hydromorphone polymorphs
HK1148007A1 (en) Valomaciclovir polymorphs
EP2170902A4 (en) Improved processes for the synthesis of olanzapine
ZA200903609B (en) Motilide polymorphs
IL214254A0 (en) Tetomilast polymorphs
EP2152811A4 (en) Novel processes of making hydroxy-1-azo-derivatives as tpo mimetics
GB201114396D0 (en) Location of basesation
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0612370D0 (en) Uses of (S)-clenbuterol
GB0621416D0 (en) Waterproof oversock
TWM300223U (en) Improved structure of drain
GB0705204D0 (en) Uses of (S)-clenbuterol
ZA200809385B (en) Novel heterocyclic compounds